Acura Pharmaceuticals updates loan schedule totaling $11,294,279
Acura Pharmaceuticals filed an exhibit amending a promissory note dated November 10, 2022 with Abuse Deterrent Pharma, LLC to include additional scheduled drawdowns through the end of 2026 and restructure the document's balance, impacting the drugmaker's long-term capital obligations.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed